PS01.53: First-Line Atezolizumab Plus Chemotherapy in Chemotherapy-Naive Patients with Advanced NSCLC: A Phase III Clinical Program
Robert M. Jotte, Mark A. Socinski, Martin Reck et al. · Journal of Thoracic Oncology · 2016
Cited by 5 works. doi:10.1016/j.jtho.2016.09.088 Open-access PDF